gvtcx

Purchase of a mid-throughput DNA genotyping analysis system

MHRA Buyer Organisation Published 31 Jan 2023 Contracts Finder

key details

Value£286,000
Statuscomplete
Category (CPV) 38000000
Deadline14 Nov 2022
Contract start20 Jan 2023
Contract end20 Jan 2028
Procedureopen
SME suitableYes
OCIDocds-b5fd17-dd4d9f54-af93-4e45-9901-7df1c29f86ae

Award

SupplierValueDateStatus
Agena Bioscience GmbH £286,000 25 Jan 2023 active

description

The Agency is looking to purchase a new integrated, substantially automated platform capable of performing mid-throughput SNP genotyping, DNA Methylation analysis, Quantitative Gene Expression Analysis and Allele frequency determination on pooled samples of DNA.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
13 Oct 2022 Tender (tender) · 248f8a5b-7eee-432d-ae3c-a4ae8c01a146-580417
31 Jan 2023 Award (award) · 45442f59-f251-4a23-bcef-e32bb7aa0ed1-610398

more from MHRA Buyer Organisation

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.